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Introduction
▼The challenge phage system is a genetic approach for
characterizing DNA-protein interactions. The principle be-
hind the method is to place the expression of a phage re-
porter gene under the control of a specific DNA-protein
interaction (Ref. 1, 2, 3). This approach can be applied to a
wide variety of DNA-binding proteins because most specific
DNA-binding proteins can act as repressors if their binding
sites are placed close enough to the promoter (Ref. 4). The
system has also been adapted to study RNA-protein inter-
actions (Table 1; Ref. 5, 6).
Challenge phage use the P22 ant gene as the reporter. The
phages are engineered so that expression of ant determines
the lysis-lysogeny decision of P22 (Ref. 7). Expression of ant
is controlled by a specific DNA-interaction which provides
a simple, sensitive genetic selection for mutations in the
DNA-binding site that increase or decrease the strength of
theDNA-protein interaction. These features provide general
methods for measuring relative in vivo affinities of DNA-
binding proteins for target sites and for identifying specific
base-pairs in DNA that contact the protein. In addition,
challenge phages can be constructed where ant expression
is regulated by the assembly of nucleoprotein complexes
containing several different proteins (Ref. 8, 9). This fea-
ture provides a method to define cooperative interactions
between DNA-binding proteins and to analyze the abilities
of mutant proteins to form complexes.
P22 has two regulatory regions that control the decision
between lysis and lysogeny (Ref. 10, 11). One region, called
immC, encodes the c2 repressor which represses transcrip-
tion from the PL and PR promoters. The c2 repressor is
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required to establish and to maintain lysogeny. P22 also
has a second regulatory region, called immI, which con-
tains the ant(antirepressor), arc(antirepressor control) and
mnt(maintenance) genes. Ant binds noncovalently to c2
repressor and inactivates it. Expression of Ant is negatively
regulated by the Arc and Mnt proteins.
Challenge phages have three alterations in the immI re-
gion that affect the lysis-lysogeny decision. They contain a
cassette encoding kanamycin resistance (KanR) in the mnt
gene, an arc(Am) mutation that inactivates Arc, and a sub-
stitution of a DNA-binding site for Omnt. Binding of the
cognate protein to the substituted site is the only method
of regulating transcription from Pant and thus controls the
decision between lysis and lysogeny. If no protein is bound
to the substituted site, ant is expressed and the infected host
cell is lysed. If the protein binds to the site, ant expression
is repressed and the phage forms a KanR lysogen. The effi-
ciency of lysogeny is typically 10−1 if the host makes a pro-
tein that recognizes the substituted site and less than 10−7
if the site is not recognized. Challenge phage containing
ant::lacZ or ant::cam fusions can also be constructed by ge-
netic recombination. Isolation of the ant::lacZ or ant::camly
sogens provides a single copy chromosomal fusion as a re-
porter gene (Ref. 12).
Protocols for construction and use of challenge phage are
detailed below. Basic phage biology, molecular biology, and
genetic protocols can be found in (Ref. 13).
Methods
Construction of challenge phages
Challenge phage are constructed in two steps. First, the
DNA-binding site is cloned into a plasmid that carries the
P22 immI region. The plasmid pPY190 is a pBR322 deriva-
tive that carries a 500 bp EcoRI-HindIII fragment from the
immI region (Fig. 1). The immI DNA cloned onto pPY190
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Table 1. Some examples of DNA-protein and RNA-protein interactions characterized using challenge
phagea
DNA-protein interaction Source Ref.
λ Repressor Phage λ (Ref. 19)
Cro repressor Phage λ (Ref. 19)
Integrase Phage λ (Ref.20, 21
Fis-Xis-Int Phage λ (Ref. 9)
attL Complex Phage λ (Ref.8, 14)
EcoRI RY13 plasmid (Ref. 22)
TetA repressor Tn10 (Ref. 7)
TrpR repressor E. coli (Ref.1, 23)
LacI repressor E. coli (Ref. 7)
GalR repressor E. coli (Ref. 7)
Integration host factor E. coli (Ref.24, 25, 26, 27
Hin recombinase S. typhimurium (Ref. 12)
PutA repressor S. typhimurium (P. Ostrovsky and S. Maloy, unpublished)
Nac activator Klebsiella aerogenes (Ref. 28)
ToxR Vibrio cholerae (Ref. 29)
nifH promoter Rhizobium meliloti (Ref. 30)
FLP recombinase S. cervesiae (Ref. 31)
RNA-protein interaction
Coat proteins Phage R17 and MS2 (Ref. 6,3232)
aNumerous other DNA-protein interactions have been studied as well. The critical requirement for any specific DNA-protein
interaction is that the protein is expressed and active in Salmonella.
includes Pantand the 5′ end of arc. The Omntsite has been
replaced with SmaI and EcoRI sites. Blunt-ended DNA frag-
ments, such as complementary oligonucleotides or restric-
tion fragments, can be cloned into the SmaI site. This places
the insert 3 bp upstream of the initiation site of Pant.The
presence of the insert can easily be verified by PCR analysis.
The substitution in pPY190 can be moved onto P22
mnt::Kan arc(Am) (P22-1000) by homologous recombina-
tion in vivo. A host containing the plasmid is infected with
the phage and a lysate is prepared. During lytic growth,
the phage and the plasmid can undergo recombination
between the sequence homology on the plasmid and the
phage. Recombinant phage that contain the substituted
DNA-binding site in place of Omnt can be identified by
infecting a MS1582 cells. MS1582 contains a P22 prophage
which expresses the c2 and Mnt proteins. Mnt represses
Omnt of incoming parental phages preventing lytic growth.
In contrast, phages carrying the substituted DNA-binding
site are not repressed by Mnt and, thus, express Ant, form-
ing plaques. The frequency of recombination between the
phage and plasmid is high. Typically between 10.0% of
the progeny phage are recombinants. One caveat is that
if the Salmonella host chromosome encodes the protein
that recognizes the DNA-binding site, it should be mu-
tated so that the protein does not repress the challenge
phage.
Because the parental phage carries the arc(Am) mutation
and the pPY190 plasmid contains the wild-type allele, re-
combinants are either arc(Am) or arc+, depending upon
which side of the mutation the crossover occurred. Both
types of recombinants form plaques on MS1582. The arc+
recombinants form small, turbid plaques because Arc can
partially repress Pant. The arc(Am) recombinants form large,
clear plaques that can be purified and used in subsequent
experiments.
The desired recombinants contain the DNA binding
site and the arc(Am) mutation. The Omnt substitutiton in
pPY190 contains an EcoRI site that is not present in the
parental phage, and the arc(Am)mutation destroys a Fnu4H
site (Fig. 2). Thus, the desired recombinants can be con-
firmed by PCR amplification of the immI region followed
by restriction fragment length polymorphism (RFLP) map-
ping with EcoRI and Fnu4H (Fig. 3).
Essentially any DNA-binding site can be cloned into
pPY190 and recombined onto P22 to form a challenge
phage. It is also possible to clone large fragments that con-
tain multiple DNA-binding sites. For simple DNA-protein
interactions the extent of repression of Pant by a DNA-
binding protein depends upon the proximity of the protein
to the transcription start site. For example, a consensus λ cI
binding site functions well when placed at the +1 or +4 po-
sition but does promote repression when placed at position
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FIGURE 1. Plasmid pPY190 is a 4.8 kb plasmid with the 5′ end of the mnt gene and the entire arc+ gene from the P22 immI region cloned into the
EcoRI-HindIII sites of pBR322. The Omnt was replaced with a SmaI/XmaI substitution constructed by site-directed mutagenesis. Cloning at SmaI places the
insert at -3 and cloning at XmaI places the insert at -1, relative to the transcription start site of ant.
+24 (Ref. 4). It is also possible to construct phages where
DNA looping regulates expression from Pant. In the case
of the λ attL site, repression required an IHF-mediated loop
containing an Int proteinmonomer, bound simultaneously
both to the Pantregion and to a sequence more than 50 bp
downstream of Pant(Ref. 14).
Construction of challenge phage by in vivo recombination
1. Grow the MS1883 containing a pPY190 subclone with
the desired DNA-binding site in LB broth + Amp at 37◦C
overnight.
2. Mix 106–107 plaque-forming units (pfu) of P22
mnt::Kan9 arc(Am) phage with 50 µl of the overnight cul-
ture. Leave at room temperature for 15–20 min to allow
phage adsorption.
3. Add 2 ml LBEG and grow at 37◦C with vigorous aera-
tion for 3 h or until the culture is lysed.
4. Add several drops of chloroform and vortex thor-
oughly. Allow the chloroform to settle. Pour the super-
natant (avoiding the chloroform) into a microfuge tube.
Centrifuge for 2 min in a microfuge to pellet the cell debris.
5. Transfer the supernatent to a new tube, add a few drops
of chloroform, vortex, and allow the chloroform to settle.
Store the lysate at 4◦C.
6. Dilute the lysate 1/100 by adding 10 µl to 1 ml LB
broth. Vortex.Mix 0.2ml of the diluted lysate with 0.1ml of
a fresh overnight culture of MS1582 [to give a multiplicity
of infection (MOI) < 1].
7. Leave at room temperature for 15–20 min to allow
phage adsorption.
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FIGURE 2. DNA sequence of the P22 immI region in P22 mnt::Kan arc(Am) (abbreviated P22-1000) and the corresponding region from plasmid pPY190.
The relative location and sequence of the anti-Omnt primer (5′ GATCATCTCTAGCCATGC 3′) and the intra-arc primer (5′
CCGCTACCTTGCGTACCAAATCC 3′) are shown in red. (a) The promoter sequences are indicated above or below the sequence, the Pant
transcriptional start site (marked +1), the translational start site of the arc gene, and the arc(Am) mutation in P22-1000 are indicated. The C-to-T base
change that results in the arc(Am) mutation in P22-1000 results in the loss of a Fnu4H1 site. (b) The differences in the pPY190 sequence are highlighted in
yellow. A substitution places a SmaI/XmaI and EcoR1 site adjacent to the +1 site of the arc gene. In addition, pPY190 has a Fnu4H1 site at the position
corresponding to the arc(Am) mutation in P22-1000.
8. Add 3 ml of melted TBSA to a test tube, place in a 50◦C
heating block, and allow the temperature of the TBSA to
equilibrate to 50◦C.
9. Add 3ml TBSA to the cells and phage, mix, and quickly
pour onto a LB-agar plate. Allow the top agar to solidify at
room temperature then incubate overnight at 37◦C.
10. Pick large clear plaques with sterile toothpicks and
streak for isolation on a LB-agar plate overlayed with 3
ml TBSA containing 0.1 ml of fresh MS1582. Incubate
overnight at 37◦C.
11. Pick large, clear, well-isolated plaques and streak for
isolation on a LB-agar plate overlayed with 3 ml TBSA con-
taining 0.1ml of freshMS1883. Incubate overnight at 37◦C.
12. Pick and restreak the large, clear plaques. Incubate
overnight at 37◦C. The larger, clear plaques contain poten-
tial recombinant challenge phage.
Identification of challenge-phagerecombinants by RFLP mapping
The desired challenge-phage recombinants have an RFLP
that can be identified by digesting the immI PCR fragment
with EcoR1 or Fnu4H1.
Preparation of challenge-phage lysates
1. For each potential recombinant challenge phage to be
tested, add 0.1 ml of MS1883 to 5 ml LBEG. Prepare an
identical culture as a control. Incubate on a shaker at 37◦C
until the cells reach early exponential phase (about 1–2 h).
2. Using a sterile Pasteur pipet, plug an independent,
well-isolated, large clear plaque from the potential chal-
lenge phage and add one plaque to each tube ofMS1883. To
the control culture, add a plaque of the P22-1000 parental
phage. Incubate at 37◦C with vigorous aeration for about
3 h or until lysed.
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FIGURE 3. Restriction maps of PCR products from the immI region in pPY190. The primers used are indicated in red. The arc gene is indicated by the
black box and the ant gene is indicated by the gray box. The EcoR1 site labeled R1a and the Fnu4H1 site labeled 4H1b are present in pPY190 but not in
P22-1000. The presence of a cloned fragment in the SmaI or XmnI site will increase the size of the 73 bp EcoR1 and 129 bp Fnu4H1 fragments. (a) PCR
with the anti-Omnt and Intra-ant primers yields a 979 bp fragment. (b) PCR with the anti-Omnt and intra-arc primers yields a 185 bp fragment.
3. Add several drops of chloroform, vortex, allow the
chloroform to settle, then transfer the supernatent (avoid-
ing the chloroform) to microfuge tubes. Centrifuge for 2
min in a microfuge to pellet the cell debris.
5. Transfer the supernatent from each phage into clean
microfuge tubes. Centrifuge for 30 min at 4◦C in a mi-
crofuge to pellet the phage.
6. Carefully pour off the supernatent. Add 0.1 ml 0.85%
NaCl to each phage pellet and vortex to resuspend the
phage. Combine the supernatents from a single phage into
one tube. Add several drops of chloroform and vortex. Store
the concentrated lysate at 4◦C.
PCR and RFLP analysis
1. Phage lysates can be amplified directly without purifying
phage DNA. Include the parent P22-1000 and a challenge
phage with the Pantregion of pPY190 recombined onto P22
arc(Am) as controls.
2. Combine the following in a 500 µl microfuge tube:
10 µl P22 lysate
1 µl Intra-Arc primer (20 pmol; 5′ CCG CTA CCT TGC GTA
CCA AAT CC 3′) or intra-Ant primer (20 pmol; 5′ CAA
GGC TGT TTG CTT CTT TTG CAG 3′)
1 µl Anti-Omnt primer (20 pmol; 5′ GAT CAT CTC TAG
CCA TGC 3′)
37 µl Sterile deionized H2O
10 µl 10 × PCR buffer (supplied by the manufacturer)
10 µl Each of 2 mM dATP, dGTP, dTTP, and dCTP
1 µl Taq DNA polymerase, 2.5 u/µl (Perkin-Elmer Corpora-
tion)
3. Mix and amplify in a thermocycler using the following
program:
95◦C, 90 sec,
53◦C, 30 sec,
74◦C, 60 sec,
cycle steps 1–3, repeat 30 times
74◦C, 5 min
4◦C, hold
4. Purify the PCR products by phenol extraction followed
by ethanol precipitation or by using a commercially avail-
able method such as Qiagen Affinity columns (Qiagen),
Wizard Preps (Promega), or Millipore MC filters (Millipore).
5. In separate tubes digest 10 µl of the PCR product with
EcoRI and Fnu4H (NEB).
6. Electrophorese the DNA and undigested controls on
a 3.0% NuSieve GTG (FMC) or 3:1 agarose gel (Sigma) in
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1 × TBE at 100 volts until the bromphenol blue is 3/4 the
length of the gel. Include a lane with low molecular weight
standards.
7. Stain the gel with ethidium bromide. Visualize with
UV and photograph. Compare the restriction digests with
the expected results for P22-1000 and pPY190 shown in
(Fig. 3).
Challenge-phage DNA-binding assays
The challenge-phage assay depends upon binding of a pro-
tein to the cognate DNA-binding site. To vary the levels of
a DNA-binding protein for use with challenge phage, it is
usually necessary to express the DNA-binding protein un-
der the control of a regulated promoter, such as Plac, Ptac,
or PBAD. The genetic background of the host strain will
depend upon the type of regulated promoter used: for Plac
and Ptac the lacIq gene should be provided on a plasmid;
for PBAD the chromosomal copy of the ara operon should
be deleted.
When a DNA-binding protein is expressed from a regu-
lated promoter, the relative in vivo affinity of a DNA-binding
protein for the binding site on the challenge phage can be
quantitated bymeasuring the frequency of KanR lysogens in
media with different concentrations of inducer (and hence
different concentrations of the DNA-binding protein). The
relative DNA-binding affinity can be expressed by plotting
the log(percent lysogeny) vs the log[inducer].
The procotols below are based upon the regulated ex-
pression of a DNA-binding protein from the Ptacpromoter
under the control of the lacIq gene product. In this case,
expression of the DNA-binding protein is induced by the
addition of isopropyl-β-D-galactopyranoside (IPTG). Typi-
cally 0.1–1 mM IPTG results in maximal induction from
Ptac. However, the optimal concentration of IPTG for each
specific DNA-binding protein should be determined em-
pirically by testing 10-fold dilutions of IPTG to ascertain
the concentration that promotes maximal lysogeny of the
challenge phage. The cell viability should be measured at
each concentration of inducer because overexpression of
DNA-binding proteins often inhibits cell growth. All of the
dilutions can be done in microtiter plates. Using a multi-
channel pipettor, 48 samples can be spotted onto each agar
plate for phenotypic selection or screening.
Challenge-phage assays
1. Titer the challenge phage on MS1883.
Subculture 50 µl of MS1868 cells with the Ptac-DNA-
binding protein expression plasmid into 2ml LB-broth con-
taining an appropriate antibiotic to maintain selection for
the expression plasmid. Incubate on a shaker at 37◦C for
about 1–2 h until the cells reach early exponential phase.
3. Subculture 0.5 ml of the early exponential phase cul-
ture into 1.5 ml of LB broth with antibiotic, and LB broth
with antibiotic and IPTG. Incubate on a shaker at 37◦C for
about 1-2 h until the cells reach early exponential phase.
4. Prepare serial 10-fold dilutions of both cultures to 10−5
in LB-broth. To determine the viable cell count, remove 5
µl from the 10−3, 10−4, 10−5dilutions and spot onto LB-
agar plates. Add 100 µl LB-broth to each spot and spread.
Incubate the plates overnight at 37◦C.
5. Calculate the volume of each phage required to give
an MOI of 10–50 pfu/cell. For example, if the cultures are at
about 108 cells per ml, for an MOI of 25, add the calculated
volume of each challenge phage lysate to 0.1 ml of the
undiluted cells. Include a P22-1000 phage control.
6. Mix the cells and phage by gently pipeting the solution
up and down then leave at room temperature for 1 h to
allow phage adsorption and phenotypic expression.
7. Prepare sequential 10-fold dilutions of each infected
cell culture to 10-4 in LB-broth.
8. Remove 10 µl from the 10−1, 10−2, 10−3, and 10−4
dilutions of infected cells grown without IPTG and spot
onto a LB-agar-Kan with antibiotic plate.
9. Remove 10 µl from the 10−1, 10−2, and 10−3 dilutions
of the cells grown with IPTG and spot onto a LB-agar-Kan
with antibiotic and IPTG plate.
10. Allow the spots to dry at room temperature then in-
cubate for 1–2 days at 37◦C.
11. Count the number of colonies on each plate. Calcu-
late the number of KanR lysogens per viable cell. If the DNA-
binding protein is properly expressed, challenge phage will
form KanR lysogens at a much higher frequency in cells
grown with inducer than in cells grown without inducer,
and the control phage will not form KanR lysogens at a
significant frequency in either condition.
Selection for DNA-binding site mutations
Challenge phage form lysogens on a host that expresses a
DNA-binding protein that binds to the substituted Omnt
site. It is possible to select for ’operator constitutive’ (Oc)
mutations in the DNA-binding site by isolating challenge
phage mutants that are not repressed by the DNA-binding
protein and, thus, form plaques on a lawn of cells that ex-
press the DNA-binding protein. This provides a very strong
selection for mutations that affect the DNA-protein inter-
action in vivo. Mutations in a DNA-binding site are usually
rare, but the resulting plaques can be easily selected from a
population of >108 infecting phage.
DNA-binding site mutants can be the result of sponta-
neous mutagenesis. However, spontaneous mutants are of-
ten due to deletion mutations, which are less valuable for
defining DNA-protein interactions than point mutations.
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The frequency of point mutations can be enhanced by mu-
tagenizing the phage. It is useful to use several mutagens
with different specificities to obtain a wide spectrum of
mutations (Ref. 13). Two methods of mutagenesis that are
particularly useful are UV mutagenesis and hydroxylamine
mutagenesis. Phage can be treated directly with both of
these mutagens in vitro.
Using this approach, it is possible to isolate a large
number of Oc mutations quickly in the substituted DNA-
binding site. The resultingmutations define critical residues
of the DNA-binding site that are necessary for recogni-
tion by a DNA-binding protein. Many DNA-binding sites
are palindromes bound by identical subunits of dimeric
regulatory proteins: each monomer recognizes one of the
half-sites. For palindromic DNA-binding sites, it might
be necessary to construct symmetric, double mutants
to determine their effect on DNA binding. Such sym-
metric, double mutants can be constructed by cloning
the appropriate double-stranded oligonucleotide into the
SmaI site of pPY190 to yield the corresponding challenge
phage.
In the following procedure, the challenge phage are mu-
tagenized with UV light. A Salmonella typhimurium strain
carrying a plasmid that expresses the cognate DNA-binding
protein and a second compatible plasmid carrying the
mucA+B+ genes is infected with the irradiated phage. The
mucAB gene products increase the frequency of error-
prone repair of UV-induced DNA damage. Clear plaque
mutations that inactivate the binding site will be rare
(typically about 10-6 to 10-7) and the background will
have numerous faint turbid plaques. Therefore, it is nec-
essary to plaque purify the clear plaque mutants several
times.
Isolation of mutations in a DNA-binding site
1. Grow an overnight culture of the MST2781 cellswith the
Ptac-DNA-binding protein expression plasmid in 2 ml LB
broth with Tet and antibiotic at 37◦C.
2. Subculture 0.1 ml of the overnight culture into 2 ml
LB-broth with Tet and antibiotic. Incubate with vigorous
aeration at 37◦C for 2–3 h or until mid-exponential phase.
3. Dilute 0.5 ml of the mid-exponential phase culture
into 1.5 ml LB broth with Tet and antibiotic and IPTG.
Incubate the cells for 1–2 h with vigorous aeration at 37◦C.
4. Dilute the challenge phage to approximately 109
pfu/ml in 0.85% NaCl (final volume needed is 1 ml). Save
0.5 ml of the diluted phage as a control.
5. Place 0.5ml of the diluted phage in a small sterile petrie
dish, remove the lid, and UV irradiate to 12 000 µJ/cm2.
6. Prepare serial 10−1 and 10−2 dilutions of the UV irra-
diated phage and the control phage in 0.85% NaCl.
7. Mix 200 µl of the IPTG-induced culture with 100 µl of
each phage dilution.
8. Leave at room temperature for about 20 min to allow
phage adsorption.
9. To each mixture of cells and phage, add 3 ml TBSA top
agar that has been melted then cooled to 50◦C. Mix gently
then quickly pour onto an LB-agar plate and swirl the plate
to cover the surface evenly. Allow the top agar to solidify for
about 15min at room temperature then incubate overnight
at 37◦C.
10. Examine the plates for clear plaques.
Purify clear plaque mutants
1. Subculture 0.1 ml of the overnight culture of TH564
cells with the Ptac-DNA-binding protein expression plas-
mid into 2 ml LB broth and antibiotic. Incubate with vig-
orous aeration at 37◦C about 2–3 h until the cells reach
mid-exponential phase.
2. Dilute 0.5ml of themid-exponential phase culture into
1.5 ml LB broth with antibiotic and 1 mM IPTG. Incubate
the cells for 1–2 h with vigorous aeration at 37◦C.
3. Add 0.1 ml of the culture induced in LB broth with
antibiotic and 1 mM IPTG to 3 ml TBSA that has been
melted then cooled to 50◦C. Mix gently then quickly pour
onto an LB broth and 1 mM IPTG plate and swirl the plate
to cover the surface evenly. Allow the top agar to solidify
at room temperature.
4. Pick large clear plaques from challenge phage with
an Oc mutation in the DNA-binding site and streak on
the cell lawn. Also streak out the unmutagenized challenge
phage and P22-1000 as controls. Incubate the plates at 37◦C
overnight.
5. The next day, add 0.1 ml of a fresh, overnight culture
of MS1883 to 3 ml TBSA that has been melted and cooled
to 50◦C. Mix gently then quickly pour onto an LB-broth
plate and swirl the plate to cover the surface evenly. Allow
the top agar to solidify at room temperature.
6. Pick large clear plaques from step 4 and restreak on the
MS1883 lawn. Incubate the plates at 37◦C overnight.
7. Remove a well-isolated large clear plaque from each
streak with a sterile Pasteur pipet.
8. Add the agar plug to 2 ml LBEG. Vortex. Add 0.1 ml
of an overnight culture of MS1883. Incubate with vigorous
aeration at 37◦C for about 3 h or until the culture lyses.
9. Centrifuge for 1 min in a microfuge to pellet the cells
and debris.
10. Pour the supernatent into a clean tube. Add several
drops of chloroform and vortex.
11. Titer the phage on MS1883. Assign allele numbers
to the mutants and save pickates of the mutant phage
lysates at 4◦C. The DNA sequence of the mutations can
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Table 2. Host strains for challenge-phage experiments
Strain Speciesa Genotype Source
MS1363 St leuA414(Am) Fels-supE40 M. Susskindb
MS1868 St leuA414(Am) Fels- hsdSB (r-m+) M. Susskind
MS1882 St leuA414(Am) Fels-hsdSB (r-m+) endA M. Susskind
MS1883 St leuA414(Am) Fels- hsdSB (r-m+) supE40 M. Susskind
MS1582 St leuA414(Am) Fels- supE40 ataP::
[P22 sieA4416(Am)H1455 Tpfr49] (Ref. 7)
MST2781 St leuA414(Am) Fels- hsdSB (r-m+) supE40 ataP::
[P22 sieA44(mnt-a1 Tn1) Amps 9- Tpfr184]/
pGW1700 (mucA+B+TetR) (Ref. 13)
MST2786 St leuA414(Am) Fels- hsdSB (r-m+) /
pGW1700 (mucA+B+TetR) (Ref. 13)
TH564 St leuA414(Am) Fels- supE40 ataP::
[P22 sieA44(mnt-a1 Tn1) Amps 9- Tpfr184] (Ref. 12)
EM425 Ec F- supE44 recA1 gyr-96 thi-1 endA
hsdR17 (r-m+) λ- / pPY190 (Ref. 13)
aStindicates Salmonella typhimurium LT2 derivatives and Ec indicates Escherichia coli K-12 derivatives. A kit with these strains can be
obtained from the authors.
bM. Susskind, Department of Molecular Biology, University of Southern California.
be determined by PCR using the anti-Omnt and intra-arc
primers or by subcloning the EcoRI fragment that carries
the Omnt substitution and mnt::Kan onto a plasmid and
sequencing the plasmid DNA.
Bacteria and phage
The S. typhimurium host strains for growing P22 challenge
phage are shown in (Table 2). Although S. typhimurium
can cause gastrointestinal infections in humans, the S. ty-
phimurium LT2 strains used for challenge phage assays are
not very virulent in humans (Ref. 15, 16). However, S. ty-
phimurium can cause infections in immunocompromised
hosts and many of the strains carry drug-resistance plas-
mids or transposons that could be transferred to other en-
teric bacteria. Therefore, good microbiological technique
should be followed when working with Salmonella [see the
CDC recomendations for Biosafety in Microbiological and
Biomedical Laboratories (http://siri.org/library/cdc.html)].
A typical P22 lysate contains about 1011 phage perml and
is stable formany years when stored over chloroform at 4◦C.
Lytic growth is favoured when the host cells are growing
rapidly and the MOI is low. Lysogeny is favored when cells
are growing slowly and the MOI is high. When the MOI of
P22 is greater than 10, more than 95% of the infected cells
form lysogens (Ref. 17). P22 diffuses rapidly throughout a
soft agar overlay on a petri dish upon extended storage. This
can result in contamination of one plaque with phage from
a nearby plaque. Therefore, to ensure the genetic homo-
geneity of phage lysates, recombinant phage should be pu-
rified by streaking for isolated, single plaques several times
before growing large-scale lysates.
Reagents
Antibiotics (Sigma or Amresco): When needed, add antibi-
otics to LB medium at the following concentrations:
50 µg/ml kanamycin sulfate (Kan), 20 µg/ml tetracy-
cline hydrochloride (Tet), 50 µg/ml sodium ampicillin
(Amp), 50 µg/ml spectinomycin dihydrochloride.
E medium (Ref. 13, 18): 5 × E medium contains 1 g
MgSO4*7H2O, 10 g Citric acid*H2O, 50 g K2HPO4, and
17.5 g NaHNH4PO4*2H2O in 1000 ml deionized H2O.
LBEG (Ref. 13): 1 × LB-broth containing 1 × E medium and
0.2% glucose.
TBSA (Ref. 13): 10 g tryptone, 5 g NaCl, and 7 g agar in 1 l
deionized H2O.
Luria-Bertani broth (LB-broth): LB-broth contains 10 g tryp-
tone, 5 g yeast extract, and 5 g NaCl in 1000 ml deion-
ized H2O. LB-agar contains agar at 15 g/l LB broth.
TE: 10 mM TrisHCl, 1 mM EDTA, pH 8.
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Products Used
Taq DNA Polymerase: Taq DNA Polymerase from
Boehringer Mannheim
Taq polymerase: Taq polymerase from Pharmacia
Taq polymerase: Taq polymerase from Bioline
Taq polymerase: Taq polymerase from Boehringer
Mannheim
Taq polymerase: Taq polymerase from Boehringer
Mannheim
Qiagen affinity columns: Qiagen affinity
columns from QIAGEN GmbH
Wizard Preps: Wizard Preps from Promega Corpo-
ration
Millipore MC filters: Millipore MC filters from
Temporary record
NuSieve: NuSieve from FMC BioProducts
NuSieve: NuSieve from FMC BioProducts
agarose gel: agarose gel from Sigma
agar: agar from Difco
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